Risk of subclinical atherosclerosis in patients with antiphospholipid syndrome and subjects with antiphospholipid antibody positivity: a systematic review and meta …
P Karakasis, E Lefkou, K Pamporis, V Nevras… - Current Problems in …, 2023 - Elsevier
Currently, the guidelines for the prevention of atherosclerosis in patients with
antiphospholipid syndrome (APS) do not differ substantially from those in the general …
antiphospholipid syndrome (APS) do not differ substantially from those in the general …
Anticardiolipin antibodies and recurrent coronary events: a prospective study of 1150 patients
A Bili, AJ Moss, CW Francis, W Zareba, LFM Watelet… - Circulation, 2000 - Am Heart Assoc
Background—The association of anticardiolipin (aCL) antibodies with coronary artery
disease has been shown in several studies but remains controversial. We evaluated the …
disease has been shown in several studies but remains controversial. We evaluated the …
Antiphospholipid antibodies as non-traditional risk factors in atherosclerosis based cardiovascular diseases without overt autoimmunity. A critical updated review
The role of antiphospholipid antibodies (aPL) associated with cardiovascular diseases has
been extensively studied in autoimmune patients, however it was largely unknown whether …
been extensively studied in autoimmune patients, however it was largely unknown whether …
Prevalence of antiphospholipid syndrome in patients under 65 years of age with acute myocardial infarction
M Seijas, A Rivera, N Rayo, J Ordi-Ros… - Revista Clinica …, 2001 - europepmc.org
Background The antiphospholipid antibody syndrome (AAS), which is characterized by
thromboembolic events and/or fetal loss and/or low platelet count associated with …
thromboembolic events and/or fetal loss and/or low platelet count associated with …
The clinical significance of anticardiolipin antibody levels in patients with acute myocardial infarction: a regional study
F Erta, Ö Can, H Acet, M Ozbakkaloglu - Advances in Interventional …, 2013 - termedia.pl
Aim: In this study, we investigated the relations between acute myocardial infarction and anti-
phospholipid antibody syndrome in our population representing Aegean Region people …
phospholipid antibody syndrome in our population representing Aegean Region people …
[HTML][HTML] Association between peptidoglycan recognition protein-1 and incident atherosclerotic cardiovascular disease events: The Dallas heart study
NK Brownell, A Khera, JA de Lemos, CR Ayers… - Journal of the American …, 2016 - jacc.org
Peptidoglycan recognition protein-1 (PGLYRP-1) is a secreted, circulating protein that binds
peptidoglycan and promotes inflammation through the activation of innate immune …
peptidoglycan and promotes inflammation through the activation of innate immune …
Alkaline phosphatase-to-albumin ratio as a novel predictor of long-term adverse outcomes in coronary artery disease patients who underwent PCI
XY Dai, YY Zheng, JN Tang, W Wang, QQ Guo… - Bioscience …, 2021 - portlandpress.com
Background: Alkaline phosphatase (ALP) and albumin (ALB) have been shown to be
associated with coronary artery disease (CAD), and it has been reported that alkaline …
associated with coronary artery disease (CAD), and it has been reported that alkaline …
Non-criteria antiphospholipid antibodies: Risk factors for endothelial dysfunction in women with pre-eclampsia
L Belmar Vega, G Fernandez Fresnedo, J Irure Ventura… - Life, 2020 - mdpi.com
The association between unconventional antiphospholipid antibodies and pre-eclampsia in
patients without thrombotic manifestations and its relationship with endothelial dysfunction …
patients without thrombotic manifestations and its relationship with endothelial dysfunction …
Lipopolysaccharide-binding protein (LBP) is associated with total and cardiovascular mortality in individuals with or without stable coronary artery disease–results …
PM Lepper, ME Kleber, TB Grammer, K Hoffmann… - Atherosclerosis, 2011 - Elsevier
BACKGROUND: Atherosclerosis of coronary arteries is hallmarked by non-specific local
inflammatory processes accompanied by a systemic response. Lipopolysaccharide-binding …
inflammatory processes accompanied by a systemic response. Lipopolysaccharide-binding …